Please Share::
Expect healthy operating performance
We believe strong pricing will continue to help large FMCG companies post healthy
topline growth with volume growth below 5%. However, smaller consumer
companies will grow at a faster pace. Revenues for our coverage universe will
continue to grow by 13.7% YoY in Q4FY15. We expect operating margin expansion
of 108bps with all companies (except Speciality Restaurant) posting margin
expansion. Operating profit and PAT are expected to grow 20% YoY and 19%
respectively. We expect positive surprise from IFB Industries and Talwalkars but
negative surprise from Speciality Restaurants.
�� India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details ��
��
-->
Expect healthy operating performance
We believe strong pricing will continue to help large FMCG companies post healthy
topline growth with volume growth below 5%. However, smaller consumer
companies will grow at a faster pace. Revenues for our coverage universe will
continue to grow by 13.7% YoY in Q4FY15. We expect operating margin expansion
of 108bps with all companies (except Speciality Restaurant) posting margin
expansion. Operating profit and PAT are expected to grow 20% YoY and 19%
respectively. We expect positive surprise from IFB Industries and Talwalkars but
negative surprise from Speciality Restaurants.
�� India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details ��
��
Strong pricing to help topline growth: We expect 13.7% YoY sales growth for
our coverage universe. Large cap MNC companies, Colgate, GSK Consumer and
Nestle, are expected to report ~2-5% volume growth with ~13-16% revenue
growth. Growth will continue to be led by strong pricing as volume growth will be
low. We expect midcap companies to post higher growth with Talwalkars Better
Value Fitness and La Opala posting 26% and 24% revenue growth respectively
with IFB posting 13.4% topline growth despite high base. Negative SSSG will
impact growth for Speciality Restaurants.
Strong margin expansion across companies: We have modeled operating
margin expansion of 108bps YoY for companies under coverage. Softening
commodity prices will continue to benefit most companies during the quarter.
Hence we have modelled ~150bps gross margin expansion for both Nestle and
GSK Consumer and 290bps for Colgate. IFB Industries will show strong margin
expansion on the back of low base and healthy topline growth. La Opala and
Talwalkars’ margins will expand while Speciality Restaurants will post a decline on
the back of low topline growth and decline in SSSG. Operating profit will grow by
20% YoY for the coverage universe.
Healthy profit growth across companies: PAT for our coverage universe is
expected to grow by 13.7% YoY with benefits from declining commodity cost
aiding margin expansion. Nestle is expected to post healthy PAT growth of 21%
on the back of strong EBIDTA growth coupled with margin expansion. Colgate
and GSK Consumer’s PAT will grow by ~14-17%YoY. Among small cap stocks, IFB
Industries will grow by 64% on the back of margin expansion while Talwalkars and
La Opala are expected to grow by ~33% each. Speciality Restaurants will continue
to disappoint with PAT decline of ~72%.
Valuation & Risk: We prefer midcap companies over large caps. Talwalkars Better
Value Fitness (Buy) and IFB Industries (Buy) continue to be our top picks in the
consumer space. We have Hold ratings on Speciality Restaurants on the back of low
revenue growth and La Opala due to steep valuations despite long term potential.
We maintain negative bias on large MNC FMCG companies on the back of steep
valuations and subdued financial performance. We have Sell rating on Colgate,
Nestle and Hold on GSK Consumer Healthcare. Key upside
lower A&P spends and faster than expected volume growth.
No comments:
Post a Comment